High-Strength Wegovy; Aldosteronism Outcome Definitions; Insulin Unit Price Down 42%

Watchdoq January 21, 2025
(MedPage Today) -- Patients treated with semaglutide 7.2 mg achieved a 20.7% weight loss after 72 weeks compared with a reduction of 17.5% with semaglutide 2.4 mg (Wegovy) and 2.4% with placebo, results from the phase IIIb STEP UP trial showed...

Read Full Article